- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
ZN.1: 9 residues within 4Å:- Chain A: D.11, H.13, D.60, H.93, H.195, H.218, R.370
- Ligands: ZN.2, KYK.4
4 PLIP interactions:3 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.11, A:H.13, A:D.60, H2O.2
ZN.2: 7 residues within 4Å:- Chain A: D.60, N.92, H.93, H.195, H.218
- Ligands: ZN.1, KYK.4
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:D.60, A:H.195, A:H.218
ZN.5: 9 residues within 4Å:- Chain B: D.11, H.13, D.60, H.93, H.195, H.218, R.370
- Ligands: ZN.6, KYK.8
4 PLIP interactions:3 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.11, B:H.13, B:D.60, H2O.10
ZN.6: 7 residues within 4Å:- Chain B: D.60, N.92, H.93, H.195, H.218
- Ligands: ZN.5, KYK.8
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:D.60, B:H.195, B:H.218
- 2 x CA: CALCIUM ION(Non-covalent)
CA.3: 7 residues within 4Å:- Chain A: K.183, N.188, K.189, I.190, D.212, G.273, N.274
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:N.188, A:D.212, A:G.273, H2O.1, H2O.7
CA.7: 7 residues within 4Å:- Chain B: K.183, N.188, K.189, I.190, D.212, G.273, N.274
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:N.188, B:D.212, B:G.273, H2O.9, H2O.15
- 2 x KYK: N6-benzyl-(alpha,beta)-methylene-ADP(Non-covalent)
KYK.4: 25 residues within 4Å:- Chain A: D.11, H.13, D.60, Q.63, N.92, H.93, D.96, L.159, S.160, N.161, H.218, S.219, N.220, R.329, N.365, G.367, G.368, R.370, F.392, G.422, E.423, F.475, D.481
- Ligands: ZN.1, ZN.2
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:D.96, A:N.161
- Hydrogen bonds: A:N.92, A:N.220, A:N.220, A:R.329, A:R.329, A:N.365, A:G.367, A:R.370, A:R.370, A:G.422, A:D.481, A:D.481
- Water bridges: A:E.423
- pi-Stacking: A:F.392, A:F.392, A:F.475, A:F.475
KYK.8: 25 residues within 4Å:- Chain B: D.11, H.13, D.60, Q.63, N.92, H.93, D.96, L.159, S.160, N.161, H.218, S.219, N.220, R.329, N.365, G.367, G.368, R.370, F.392, G.422, E.423, F.475, D.481
- Ligands: ZN.5, ZN.6
19 PLIP interactions:19 interactions with chain B- Hydrophobic interactions: B:D.96, B:N.161
- Hydrogen bonds: B:N.92, B:N.220, B:N.220, B:R.329, B:R.329, B:N.365, B:G.367, B:R.370, B:R.370, B:G.422, B:D.481, B:D.481
- Water bridges: B:E.423
- pi-Stacking: B:F.392, B:F.392, B:F.475, B:F.475
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bhattarai, S. et al., X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) Inhibitors for Cancer Immunotherapy. Adv Ther (2019)
- Release Date
- 2020-07-22
- Peptides
- 5'-nucleotidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x KYK: N6-benzyl-(alpha,beta)-methylene-ADP(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bhattarai, S. et al., X-Ray Co-Crystal Structure Guides the Way to Subnanomolar Competitive Ecto-5'-Nucleotidase (CD73) Inhibitors for Cancer Immunotherapy. Adv Ther (2019)
- Release Date
- 2020-07-22
- Peptides
- 5'-nucleotidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A